Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Critical Therapeutics Files For Estimated $103.5M IPO

March 22, 2004

By Aaron Lorenzo

Antigenics Pockets $14.25M For Sale Of Feline Leukemia Vaccine

March 19, 2004

By Aaron Lorenzo

Antigenics Pockets $14.25M For Sale Of Feline Leukemia Vaccine

March 19, 2004

By Aaron Lorenzo

Tercica Completes IPO With Below-Range Share Pricing

March 18, 2004

By Aaron Lorenzo

Tercica Completes IPO With Below-Range Share Pricing

March 18, 2004

By Aaron Lorenzo

From Services To Cancer: Semafore's Focus Change

March 17, 2004

By Aaron Lorenzo

From Services To Cancer: Semafore's Focus Change

March 17, 2004

By Aaron Lorenzo

ChemoCentryx, Forest Form Partnership On Chemokines

March 16, 2004

By Aaron Lorenzo

ChemoCentryx, Forest Form Partnership On Chemokines

March 16, 2004

By Aaron Lorenzo

Series C In The Past, Momenta Files For Initial Public Offering

March 15, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...